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The ability of capsaicin to excite and subsequently to desensi-
tize a select group of small sensory neurons has made it a
useful tool to study their function. For this reason, application of
capsaicin to the skin has been used for a variety of painful
syndromes. We examined whether intradermal injection of cap-
saicin produced morphological changes in cutaneous nerve
fibers that would account for its analgesic properties by com-
paring cutaneous innervation in capsaicin-treated skin with
psychophysical measures of sensation. At various times after
capsaicin injection, nerve fibers were visualized immunohisto-
chemically in skin biopsies and were quantified. In normal skin
the epidermis is heavily innervated by nerve fibers immunore-
active for protein gene product (PGP) 9.5, whereas fibers im-
munoreactive for substance P (SP) and calcitonin gene-related
peptide (CGRP) are typically associated with blood vessels.
There was nearly complete degeneration of epidermal nerve
fibers and the subepidermal neural plexus in capsaicin-treated
skin, as indicated by the loss of immunoreactivity for PGP 9.5
and CGRP. The effect of capsaicin on dermal nerve fibers
immunoreactive for SP was less obvious. Capsaicin decreased
sensitivity to pain produced by sharp mechanical stimuli and
nearly eliminated heat-evoked pain within the injected area.
Limited reinnervation of the epidermis and partial return of
sensation occurred 3 weeks after treatment; reinnervation of
the epidermis was ;25% of normal, and sensation improved to
50–75% of normal. These data show that sensory dysfunction
after capsaicin application to the skin results from rapid degen-
eration of intracutaneous nerve fibers.
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Capsaicin, the active pungent ingredient in hot peppers, is a
unique tool used to study the functions of a subset of sensory
neurons, including nociceptive neurons. Early studies focused on
the neurotoxic actions of capsaicin applied systemically in high
doses to neonatal or adult rats (for review, see Nagy, 1982;
Fitzgerald, 1983; Russell and Burchiel, 1984; Buck and Burks,
1986; Holzer, 1991). It was found that capsaicin destroys a subset
of small diameter primary afferent fibers and their cell bodies.
Topical application of capsaicin evokes burning pain, neuro-
genic inflammation (vasodilatation and plasma extravasation),
and hyperalgesia to heat and mechanical stimuli (Szolcsa´nyi,
1977; Carpenter and Lynn, 1981; Culp et al., 1989; Simone and
Ochoa, 1991). After repeated applications, the treated area be-
comes less sensitive to pain. This desensitizing action has made
capsaicin attractive for use as a peripherally acting analgesic for
chronic painful syndromes (Capsaicin Study Group, 1991; Fusco
and Giacovazzo, 1997).
Intradermal injection of capsaicin quickly deposits a quantified
amount directly into human skin. This produces a sensation of
intense burning pain and hyperalgesia to heat and mechanical
stimuli (Simone et al., 1987, 1989; LaMotte et al., 1991, 1992),
followed by a rapid desensitization characterized by diminished
pain sensation at the site of application (LaMotte et al., 1991).
Electrophysiological studies have shown that shortly after intra-
dermal injection of capsaicin, C-fiber polymodal nociceptors can
become insensitive to mechanical and heat stimuli (Baumann et
al., 1991). Furthermore, this effect of capsaicin is well localized to
the injection site because only the portion of the receptive field
exposed to capsaicin becomes desensitized. Thus, diminished
pain sensation at the site of capsaicin injection is attributed to
desensitization of nociceptors.
The mechanisms underlying rapid desensitization and hypal-
gesia after local capsaicin application in humans are unclear.
Desensitization of capsaicin-sensitive afferent fibers involves a
continuum of physiological and morphological changes that are
dependent on capsaicin dose and route of administration. The
effects of capsaicin on neural function, whether applied systemi-
cally or locally, have been categorized into various stages in
animal studies and range from conduction block with reversible
ultrastructural changes in peripheral nociceptive endings to irre-
versible degeneration of nociceptive neurons and their processes
(Szolcsa´nyi, 1993). For example, although systemic application of
high doses of capsaicin destroys certain sensory neurons, capsa-
icin applied to the peripheral nerve endings in the cornea pro-
duces swelling of mitochondria and a reduction in the number of
microvesicles in unmyelinated nerve endings without evidence of
axonal degeneration (Szolcsa´nyi et al., 1975). Morphological cor-
relates of functional desensitization after capsaicin application to
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skin are unknown. Although topical capsaicin decreased the
number of nerve fibers in the epidermis as observed in a blister
roof (Reilly et al., 1997), this was not verified by skin biopsy or
sensory testing. Therefore, in this correlative study in humans,
psychophysical measures of cutaneous sensation and immunohis-
tochemical techniques were used to determine whether the hyp-
algesia after intradermal injection of capsaicin could be attributed
to morphological changes in epidermal nerve fibers (ENFs).
A preliminary report has been published previously (Simone et
al., 1996).
MATERIALS AND METHODS
Subjects. Eight subjects (six male and two female) ranging in age from 24
to 69 years participated. Each subject provided informed consent to a
protocol that was approved by the Institutional Review Board Human
Subjects Committee of the University of Minnesota.
Intradermal injection of capsaicin. Capsaicin was dissolved in a vehicle
containing 7.5% Tween 80 in saline as described previously (Simone et
al., 1987, 1989; LaMotte et al., 1991). All injections were given into test
areas (5 mm in diameter) marked on the lateral aspect of the upper arm.
Capsaicin doses of either 0.2, 2, or 20 mg in a volume of 20 ml or an equal
amount of the vehicle was injected into each site using a 0.5 ml insulin
syringe. A maximum of seven injections were given into each shoulder.
Before each injection, the skin was anesthetized with an intradermal
injection of 1% lidocaine (0.3–0.5 ml).
Psychophysical measures of cutaneous sensation. Heat pain, pricking
pain, cold sensation, and tactile threshold were evaluated within each
5-mm-diameter test site. Thermal stimuli of 5 sec duration were applied
via a 2-mm-diameter contact probe maintained at 53°C for heat pain or
1°C for cold sensation. Subjects judged the magnitude of heat pain and
the magnitude of cold sensation using a visual analog scale ranging from
0 (no pain) to 10 (most severe pain imaginable). Heat and cold stimuli
were each applied five times, and the mean magnitude of pain and cold
sensation was determined. Pricking pain was evoked by a sharp probe
(50-mm-diameter tip) attached to a nylon monofilament with a bending
force of 95 mN. This probe did not penetrate the skin. The stimulus was
applied 10 times, each for a duration of 1–2 sec. The proportion of
stimulus presentations that evoked pain, as well as the magnitude of pain,
was recorded. Tactile threshold (in mN) was determined by the use of
calibrated Semmes-Weinstein monofilaments. Threshold was defined as
the smallest monofilament that could be perceived at least 50% of the
time. Individual monofilaments were applied 10 times beginning with a
suprathreshold stimulus. All sensory tests were performed at each test
site before and at various times after injection.
Skin biopsy and immunohistochemistry. Skin biopsies were obtained
from vehicle- and capsaicin-treated sites and occasionally from untreated
skin. After the skin was anesthetized by intradermal injection of 1%
xylocaine (Astra, Westborough, MA), the biopsy was made with a 3 mm
punch tool (Acupunch; Acuderm, Fort Lauderdale, FL) and processed as
described previously (Kennedy et al., 1996). Briefly, biopsies were fixed in
Zamboni’s solution, cryoprotected, and sectioned with a freezing sliding
microtome (Leica, Nussloch, Germany). Diluent and washing solutions
comprised 1% normal donkey serum (Jackson ImmunoResearch, West
Grove, PA) in 0.1 M PBS with 0.3% Triton X-100 (Sigma, St. Louis, MO).
Floating sections were blocked with 5% normal donkey serum in the
diluent solution. Nerve and tissue antigens were localized using primary
antibodies to protein gene product (PGP) 9.5 (1:800; Ultraclone, Isle of
Wight, England), substance P (SP) (1:1000; Incstar, Stillwater, MN),
calcitonin gene-related peptide (CGRP) (1:1000; Amersham, Arlington
Heights, IL) and type IV collagen (Chemicon, Temecula, CA), each
diluted in PBS–Triton X-100–NGS. Nonimmune serum was used for
negative controls. Secondary antibodies specific to the IgG species used
as a primary antibody and labeled with cyanine dye fluorophores 3.18 and
5.18 (Jackson ImmunoResearch) were used to locate two antigens in
each section. After immunohistochemical processing, sections were ad-
hered to coverslips with agar, dehydrated via an alcohol series, cleared
with methyl salicylate, and mounted in DPX (Fluka BioChemika,
Ronkonkoma, NY).
Imaging and quantification of ENFs. Images of sections that were
double stained with PGP 9.5 and type IV collagen were collected with a
laser-scanning confocal microscope (Bio-Rad, Hercules, CA) with a
Nikon 203 planapochromate objective (numerical aperture, 0.75) and
appropriate filters. Each image set comprised a z-series that was acquired
in 2 mm increments throughout the thickness of the section.
Quantitative analyses of ENFs were performed as described previ-
ously (Kennedy et al., 1996). Briefly, z-series image stacks of PGP
9.5-immunostained ENFs were acquired from the biopsy sections with
the confocal microscope, and the images were analyzed with Neurolucida
software (MicroBrightField, Colchester, VT) by tracing nerve fibers in
three dimensions. Individual ENFs are counted as they pass through the
basement membrane. Branching occurring within the epidermis did not
increase the number of ENFs counted. Epidermal nerve counts of PGP
9.5-immunoreactive fibers were standardized for section thickness (30
mm) and expressed as the number of fibers per millimeter of epidermis.
The subepidermal neural plexus and SP- and CGRP-immunoreactive
fibers were examined qualitatively by visual inspection with the use of
fluorescence microscopy.
Data analyses. ENFs were counted, quantified, and compared with the
number of ENFs per millimeter length in normal epidermis. A one-way
ANOVA was used to compare the number of ENFs present 3 d after
intradermal injection of vehicle and of 0.2, 2, and 20 mg doses of
capsaicin. The innervation of epidermis before and between 1 and 4
weeks after an intradermal injection of 20 mg was assessed by repeated-
measures ANOVA. Comparisons were made between the number of
ENFs in capsaicin-treated skin, vehicle-treated skin, and normal un-
treated skin.
The effect of capsaicin on psychophysical measures of heat pain sen-
sation, cold sensation, and tactile sensation and on the proportion of
sharp stimuli perceived as painful was assessed using ANOVAs with
repeated measures. Separate analyses were used to examine the effect of
capsaicin dose on the various sensory modalities and to evaluate changes
in sensation over a 4 week time period after a single injection of 20 mg of
capsaicin.
Experimental design. To determine the effect of graded doses of cap-
saicin on the sensation and morphology of ENFs, we gave each of five
subjects one set of four intradermal injections on each upper arm. A set
of injections consisted of capsaicin doses of 0.2, 2, and 20 mg and the
vehicle. Sensation was assessed and skin biopsy was performed at each
injection site after 24 hr for one set of injections and after 72 hr for the
other set.
In a separate experiment, we determined the time course and extent of
reinnervation and whether reinnervation is accompanied by the return of
normal pain sensation. Five subjects were given four intradermal injec-
tions of 20 mg of capsaicin into the upper arm. Evoked sensation and
cutaneous innervation were assessed at each injection site at 1, 2, 3, or 4
weeks after injection. Three subjects received one additional injection of
capsaicin, and measurements were also made at 6 weeks after injection.
RESULTS
Effect of capsaicin on the number of ENFs and
cutaneous sensation: dose–response relationships
In vehicle-treated skin, like normal untreated skin, PGP 9.5-
immunoreactive nerve fibers are abundant in the subepidermal
neural plexus, which lies just below the basement membrane (Fig.
1, Veh). The epidermis is richly innervated by fibers that originate
in the subepidermal plexus and project up through the basement
membrane and terminate in the epidermis. It is likely that all
nerve fibers have been visualized because PGP 9.5-
immunoreactive axons are greater in number and density and the
staining is stronger than that seen with antisera to other neural
markers (Karanth et al., 1991). It has been shown previously that
nerve fibers extending into the epidermis are unmyelinated
(Ochoa, 1984; Wang et al., 1990; Kennedy and Wendelschafer-
Crabb, 1993).
Capsaicin produced a rapid, dose-dependent degeneration of
intracutaneous nerve fibers and a dramatic decrease in the sen-
sation of pain produced by heat and mechanical stimuli. All three
doses of capsaicin caused a significant reduction in the mean
number of ENFs as compared with that in vehicle-treated skin
( p , 0.05). Although nerve degeneration was evident at 24 hr
after injection, the magnitude and spatial extent of fiber loss were
more pronounced at 72 hr after injection. An example of nerve
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degeneration after capsaicin injection is provided in Figure 1,
which shows confocal images of skin biopsies for one subject with
typical neural degeneration observed at 72 hr after injection.
After the lowest dose of capsaicin, loss of PGP 9.5-
immunoreactive nerve fibers was restricted primarily to fibers
located in the epidermis, with little to moderate disruption of
nerve fibers in the subepidermal neural plexus. Higher doses of
capsaicin resulted in complete loss of PGP 9.5-immunoreactive
ENFs plus various degrees of disruption or complete loss of the
subepidermal nerve plexus.
Nerve fibers immunoreactive for CGRP and SP are sparsely
distributed throughout the papillary dermis where they are typi-
cally associated with capillary loops. CGRP-immunoreactive
nerve fibers occasionally penetrate the epidermis, whereas SP-
immunoreactive fibers are sparse in the subepidermal neural
plexus and rarely enter the epidermis. Complete loss of CGRP-
immunoreactive fibers was also observed 72 hr after capsaicin
injection. The effect of capsaicin on SP-immunoreactive nerve
fibers was difficult to assess because very few fibers are normally
found in the superficial dermis, and after capsaicin a few SP-
immunoreactive nerve fibers were found in some subjects,
whereas no SP-immunoreactive fibers were found in other
subjects.
The relationship between capsaicin dose, somatic sensation,
and the number of PGP 9.5-immunoreactive ENFs at 72 hr after
injection is summarized for all five subjects in Figure 2. The mean
(6 SEM) decrease in the number of ENFs per length (in milli-
meters) of epidermis at 72 hr after injection of 0.2, 2, and 20 mg
of capsaicin was 43.5 6 13.2, 98.7 6 1.33, and 99.9 6 0.99%,
respectively, compared with that in vehicle-treated skin. The
decrease in the number of ENFs was associated with diminished
pain sensation. One-way ANOVAs revealed that capsaicin de-
creased the magnitude of heat pain sensation ( p , 0.001) and the
detection of sharp pain sensation ( p , 0.001). However, heat pain
sensation was more sensitive to capsaicin treatment than was
mechanical pain sensation. The magnitude of heat pain sensation
decreased significantly after injection of 2 and 20 mg of capsaicin
( p , 0.05), whereas the proportion of sharp mechanical stimuli
Figure 1. Confocal images showing innervation of epidermis and superficial dermis for one subject at 72 hr after a single injection of vehicle (Veh) or
capsaicin doses of 0.2, 2.0, or 20 mg. Nerve fibers (N) immunoreactive for PGP 9.5 appear yellow-green; the basement membrane ( B) and vessels ( V )
appear red. Scale bars, 100 mm.
Figure 2. Somatic sensation and the number of ENFs for all five subjects
at 72 hr after injection of capsaicin. Data are expressed as the mean (6
SEM) percent change from the data for vehicle-treated skin. For heat pain
and cold sensation, data represent the change in the magnitude of sensa-
tion. Mechanical pain sensation is represented as the change in the
proportion of stimuli perceived as painful.
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perceived as painful decreased significantly after the 20 mg dose
( p , 0.05). Tactile threshold was not altered significantly after
capsaicin injection, but the effect of capsaicin on this measure
varied considerably between subjects. Although the magnitude of
cold sensation did not decrease significantly, the subjective mag-
nitude of cold decreased .50% in two of five subjects after the 2
mg dose and in three of five subjects after the 20 mg dose. The
remaining subjects experienced a lesser decrement in cold sensa-
tion or no change at all. Injection of the vehicle did not produce
significant changes in any evoked sensations or in innervation
density as compared with that in normal untreated skin.
Reinnervation of the epidermis and restoration of
sensory function
To determine the extent to which ENFs regenerated after cap-
saicin as well as the time course of epidermal reinnervation, we
performed skin biopsies and sensory tests at capsaicin injection
sites 1–4 (n 5 5) or 6 (n 5 3) weeks after the injection. A one-way
ANOVA indicated a significant decrease in ENFs after capsaicin
( p , 0.001) compared with that in normal skin. All subjects
exhibited denervation in capsaicin-treated skin during the first 2
weeks after injection, and ENFs were rarely observed. Similarly,
nerve fibers in the subepidermal neural plexus were also sparse
during this time period. Reinnervation of the epidermis by ENFs
began during the third and fourth weeks after the capsaicin
injection and was characterized by the return of an intact subepi-
dermal neural plexus and the reappearance of sparse nerve fibers
in the epidermis. However, the innervation of epidermis during
this time was still dramatically impaired, and the number of ENFs
per length (in millimeters) of epidermis ranged from only 12 to
29% of that in normal skin. Figure 3 shows confocal images of
biopsy sections stained for PGP 9.5 immunoreactivity in normal
untreated skin and in skin at 1, 2, and 4 weeks after capsaicin
treatment for one subject. For this subject, who exhibited the
most reinnervation of all subjects tested, innervation of the epi-
dermis did not improve further between 4 and 6 weeks (we did
not examine at any later time).
Nerve fibers immunoreactive for CGRP also reappeared 3–4
weeks after capsaicin (Fig. 4). These CGRP-immunoreactive
nerve fibers were never observed in the epidermis or superficial
dermis 1 week after capsaicin. However, they were found in the
dermis, but not the epidermis, 4 weeks after injection of capsa-
icin. Although quantitative measures of the number of CGRP-
immunoreactive fibers were not made, the number of fibers
present at 4 weeks after capsaicin appeared to be less than
normal, as with PGP 9.5-immunoreactive fibers.
The extent of reinnervation of SP-immunoreactive nerve fibers
was difficult to assess because of the small number of fibers
normally observed in the superficial dermis and epidermis. A few
nerve fibers were found in at least some of the subjects at all times
examined after capsaicin. These fibers were observed only in the
dermis, and the number of these fibers found was similar to that
in normal skin.
Gradual reinnervation of the epidermis coincided with the
gradual restoration of evoked pain sensation. This is illustrated in
Figure 5 that shows the mean change in the number of PGP
9.5-immunoreactive ENFs and the mean change in sensation for
Figure 3. Confocal images showing denervation and reinnervation of epidermis and superficial dermis by PGP 9.5-immunoreactive nerve fibers for one
subject. Biopsies were taken from capsaicin-treated (20 mg) skin at 1, 2, and 4 weeks after injection and from normal untreated skin. The appearance
of nerve fibers immunoreactive for PGP 9.5 is the same as that described in Figure 1. Scale bars, 100 mm.
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all subjects. The magnitude of heat pain sensation and the percent
of mechanical stimuli perceived as painful decreased significantly
after capsaicin ( p , 0.001). During the first 2 weeks after cap-
saicin injection, heat pain sensation was nearly eliminated, and
subjects exhibited an ;65% decrease in the proportion of sharp
mechanical stimuli perceived as painful. However, the decrease
in mechanically evoked pain sensation was variable compared
with the changes in heat pain sensation. For example, during the
first 2 weeks after capsaicin, three of the six subjects did not
perceive sharp pain, whereas the detection of sharp pain was not
altered in one subject. Although there were no significant alter-
ations in the sensation of cold during the first 2 weeks after
capsaicin, all but one subject exhibited at least a 16% decrease in
the magnitude of cold sensation. Similarly, there was no signifi-
cant change in tactile threshold during this time. Tactile thresh-
olds were increased in three of the six subjects and were un-
changed in the remaining three subjects.
At 3 and 4 weeks after capsaicin, detection of heat pain and of
pricking pain sensation had improved and was consistent with the
onset of reinnervation of the epidermis. There remained a 37 6
Figure 4. Confocal images of skin biopsies from one subject showing nerve fibers immunoreactive for CGRP and SP in normal skin and skin at 1 and
4 weeks after capsaicin injection. Right, CGRP-immunoreactive fibers were completely absent 1 week after capsaicin injection and reappeared 4 weeks
after injection (arrows). Left, There was not a complete loss of SP-immunoreactive fibers at 1 week after capsaicin injection, and one fiber can be seen
oriented horizontally below the basement membrane (arrow). At 4 weeks after capsaicin injection, fibers were occasionally found deep in the dermis
(arrow) and oriented vertically toward the basement membrane. Scale bars, 100 mm.
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19.9% decrease in heat pain at 4 weeks after capsaicin as com-
pared with that in normal skin. Similarly, the sensation of prick-
ing pain also improved but was more variable than was the pain
sensation evoked by heat.
Localization of capsaicin-evoked nerve degeneration
To determine the extent to which capsaicin diffused from the
injection site to cause degeneration of nerve fibers adjacent to the
injection site, we made one biopsy 72 hr after injection of 20 mg
of capsaicin that included part of the injection site (as defined by
the appearance of the bleb) and adjacent skin. A confocal image
of this biopsy is provided in Figure 6. It can be seen that the lef t
portion of the biopsied skin does not contain ENFs, whereas
ENFs are clearly seen in the right portion. The right portion of the
biopsy, which has a normal appearance and number of ENFs, was
;1–2 mm from the edge of the capsaicin injection. This demon-
strates that capsaicin diffuses minimally from the injection site
and that nerve degeneration is restricted to the capsaicin-treated
area.
DISCUSSION
The present findings demonstrate that intradermal injection of
capsaicin produces rapid degeneration of nerve fibers in the
epidermis and superficial dermis. This phenomenon is local in
that it occurred only at the site of injection and presumably only
to those nerve fibers that came in contact with capsaicin. We used
loss of immunoreactivity for PGP 9.5 as evidence of degenera-
tion. It could be argued that capsaicin interferes with expression
of PGP 9.5 without producing nerve fiber destruction. However,
we believe the initial loss and subsequent reappearance of immu-
noreactivity for PGP 9.5 coincides with degeneration and subse-
quent regeneration for the following reasons. First, capsaicin
produced a clear disruption of the subepidermal neural plexus
within 3 d after intradermal injection, followed by a gradual loss
within the next 2 weeks. Second, loss of immunoreactivity also
occurred for the neuropeptide CGRP, and there appeared to be
a decrease in the number of SP-immunoreactive fibers. Third, the
reappearance of immunoreactivity for PGP 9.5 was gradual and
consistent with the gradual regeneration of the subepidermal
neural plexus and reinnervation of the epidermis. Fourth, the
number of PGP 9.5-immunoreactive fibers that reappeared was
less than that in normal skin, even at 4 and 6 weeks after capsaicin
injection. Fifth, the loss and subsequent reappearance of immu-
noreactivity for PGP 9.5 correlated well with the loss and recov-
ery of somatic sensation. The combined disappearance of immu-
noreactivity for a cytoplasmic protein and two neuropeptides and
the associated decrement in sensation strongly suggest that intra-
cutaneous nerve fibers degenerated.
Degeneration of intradermal and epidermal nerve fibers by
locally applied capsaicin raises several important issues regarding
(1) the mechanisms of hypalgesia produced by capsaicin, (2) the
mechanisms by which capsaicin produces local degeneration of
nerve fibers, and (3) the function of epidermal nerve fibers in
sensation, which are each discussed below. It is noteworthy that
capsaicin produced degeneration of ENFs in the presence of local
anesthesia. This suggests that degeneration produced by capsaicin
is not dependent on excitation and generation of action
potentials.
Hypalgesia and degeneration after capsaicin
Many studies have documented that application of capsaicin to
the skin initially produces pain and hyperalgesia followed by
diminished pain sensation, referred to as functional desensitiza-
tion. The peripheral neural mechanisms that contribute to the
positive sensory phenomena of pain and hyperalgesia produced
by intradermal injection of capsaicin include excitation and sen-
sitization of C polymodal nociceptors, whereas the neural mech-
anisms underlying functional desensitization subsequent to cap-
saicin treatment are unclear. One possibility is that capsaicin
depletes C-fibers of neuropeptides, such as SP and CGRP, result-
ing in desensitization of nociceptors. Capsaicin has been shown
to release these and other peptides from the peripheral endings of
primary afferent fibers (Holzer, 1988; Maggi and Meli, 1988;
Saria et al., 1988). Recent electrophysiological studies, however,
suggest that initial desensitization and hypalgesia are related to
the effects of capsaicin on neuronal ion channels. It has been
found that capsaicin initially excites nociceptors by interacting
with a specific receptor (Szallasi and Blumberg, 1990a,b; Caterina
et al., 1997) to decrease the input resistance (Heyman and Rang,
1985), to evoke an inward current (Bevan and Docherty, 1993),
and to open nonselective cation channels (Wood et al., 1988;
Bleakman et al., 1990; Docherty et al., 1991). This is followed by
the inactivation of voltage-gated ion channels that prevents the
generation of action potentials and may account for short-lasting
desensitization and hypalgesia. It is therefore possible that cap-
saicin interferes with the generation of action potentials by caus-
ing ultrastructural damage (e.g., mitochondrial swelling) to noci-
ceptive endings as a result of prolonged opening of cation
channels. Although the mechanisms described above may account
for initial desensitization and corresponding hypalgesia, it is
unlikely that they account for the long-lasting hypalgesia observed
in the present study. Rather, our findings demonstrate that hyp-
algesia results from the loss of nerve fibers. This is the first study
to examine the morphology of intradermal and ENFs located at
the site of capsaicin injection. Our results are compatible with a
previous study in which repeated application of topical capsaicin
to the rat hindpaw produced no evidence of either nerve damage
in the sciatic nerve (proximal to capsaicin application) or neuron
loss in the dorsal root ganglion (DRG) (McMahon et al., 1991).
Although topical capsaicin did not produce remote degeneration
of nerve fibers in the nerve trunk or of sensory neurons in the
DRG, it was not determined whether capsaicin produced degen-
eration locally at the site of application. It has been shown,
however, that systemic administration of capsaicin caused some
degeneration of the subepidermal neural plexus (Chung et al.,
1990), demonstrating susceptibility of intracutaneous nerve fibers
Figure 5. The mean (6 SEM) change in sensation and in the number of
ENFs for all subjects through 1–6 weeks after injection of 20 mg of
capsaicin. Data are presented as the percent change from normal un-
treated skin.
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to the neurotoxic actions of capsaicin. Also, local application of
capsaicin has been shown to cause degeneration of DRG neurons
and axons (Handwerker et al., 1984; Marsh et al., 1987; Pini et al.,
1990). As illustrated in the present study, degeneration occurred
only at the site of capsaicin application and in those fibers ex-
posed to the neurotoxin. Moreover, degeneration was progressive
in that only ENFs were affected at 24 hr after capsaicin, whereas
degeneration included the subepidermal neural plexus within 1
week and the dermal CGRP- and SP-immunoreactive nerve fi-
bers. This was illustrated more clearly in a parallel study (Nolano
et al., 1996) in which repeated topical application of capsaicin
produced gradual degeneration of nerve fibers in the epidermis.
Recently, Reilly et al. (1997) confirmed the use of the blister
technique to show degeneration of ENFs by capsaicin. Thus,
capsaicin seems to produce a gradual but limited dying back of
fibers from the nerve endings in the epidermis. This pattern of
degeneration is common with various types of clinical neuropa-
thies, such as diabetic neuropathy (Kennedy et al., 1996) and
neuropathy associated with human immunodeficiency virus injec-
tion (McCarthy et al., 1995).
Functions of epidermal nerve fibers
The present findings provide new information about the function
of ENFs. Because loss of ENFs correlated primarily with dimin-
ished pain sensation, we believe that many of the ENFs are
nociceptors. Furthermore, many are likely to be polymodal noci-
ceptors because pain evoked by heat and mechanical stimuli was
depressed. However, an interesting paradox is that cold and
tactile sensitivities were not altered significantly, although virtu-
ally all fibers in the superficial skin were absent. Although the
probe used for cold sensation was small and maintained at very
low temperature, it evoked cold sensation without pain. This
suggests that cold-specific receptors normally sensitive to innoc-
uous cold temperatures were excited. The finding that cold and
tactile sensations were not altered by capsaicin is in agreement
with electrophysiological studies showing that evoked responses
of low threshold receptors were not altered after intradermal
injection of capsaicin (Baumann et al., 1991). It is likely that those
sensations arose from activation of receptors located deep in the
dermis or just adjacent to the capsaicin injection where innerva-
tion is normal. Similarly, deep nociceptors or activated proximal
segments of ENFs are likely to account for the residual pricking
pain sensation that persisted after capsaicin treatment.
There seemed to be a mismatch in the relationship between the
number of regenerated ENFs and evoked sensation. During
reinnervation when there were relatively few fibers in the epider-
mis, there was a striking return of heat and sharp pain sensation.
For example, at 3 weeks after capsaicin injection, the mean
magnitude of heat pain and sharp pain sensation was 61 and 77%,
respectively, of that obtained in normal skin. At this time, how-
ever, epidermal reinnervation was only ;17% of normal. Two
possibilities might account for the apparent mismatch between
the magnitude of sensation and the number of epidermal nerve
fibers. One is that relatively few epidermal nerve fibers are
needed for pain detection. This is supported by microneurogra-
phy studies in humans that suggest activation of a small number of
nociceptive primary afferent fibers evoke clear pain sensation
(Ochoa and Torebjo¨rk, 1989). If this is true, sensory testing by
conventional methods may not be sensitive enough to detect
neuropathy in the early stages of degeneration. A second possi-
bility is that the subepidermal neural plexus and receptors located
on these fibers contribute to evoked sensation. Indeed at 3 weeks
or less after capsaicin treatment, the subepidermal neural plexus
appeared to have returned to normal, on visual inspection, with
respect to its density and continuity.
Conclusions
The present study demonstrates that the hypalgesia after appli-
cation of capsaicin to the skin results from degeneration of ENFs.
This finding has important clinical implications because topical
capsaicin has been used for a variety of painful syndromes,
including diabetic neuropathy. Because we have shown that de-
generation of ENFs also occurs after topical capsaicin, although
the degeneration has a slower onset and is not as severe as that
produced by intradermal injection (Nolano et al., 1996), it is
debatable whether capsaicin should be used in syndromes in
which there is ongoing nerve pathology and nerve regeneration is
necessary to preserve or restore detection of noxious stimuli. In
Figure 6. The localization of degeneration of ENFs after an intradermal injection of 20 mg of capsaicin as shown by confocal images of skin biopsy from
one subject. Top, Montage of confocal images that span across the skin biopsy. Abundant ENFs are seen only at the far right portion of the biopsy, which
was located outside the capsaicin injection site and presumably not exposed to the neurotoxin. Bottom, The two opposite ends of the skin biopsy, outlined
by the squares in the top image, shown at greater magnification to illustrate differences in epidermal innervation.
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this regard, the capsaicin model may be useful to study mecha-
nisms of regeneration of intracutaneous nerve fibers and to assess
the effects of neurotrophins and other pharmacological agents in
correlative morphological and psychophysical studies.
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